Journal article
Evolution of Australian Percutaneous Coronary Intervention (from the Melbourne Interventional Group [MIG] Registry)
J Yeoh, D Eccleston, W Wilson, AE Ajani, MB Yudi, DJ Clark, N Andrianopoulos, BP Yan, SJ Duffy, A Brennan, CM Reid, G New, M Freeman, M Sebastian, E Oqueli, JA Shaw, A Walton, A Dart, A Broughton, J Federman Show all
American Journal of Cardiology | EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC | Published : 2017
Abstract
Percutaneous coronary intervention (PCI) continues to evolve with shifting patient demographics, treatments, and outcomes. We sought to document the specific changes observed over a 9-year period in a contemporary Australian PCI cohort. The Melbourne Interventional Group is an established multicenter PCI registry in Melbourne, Australia. Data were collected prospectively with 30-day and 12-month follow-ups. Demographic, procedural, and outcome data for all consecutive patients were analyzed with a year-to-year comparison from 2005 to 2013. National Death Index linkage was performed for long-term mortality analysis; 19,858 procedures were captured over 9 years. Patient complexity and acuity i..
View full abstractGrants
Funding Acknowledgements
The Melbourne Interventional Group acknowledges funding from Abbott, Astra-Zeneca, Biotronik, Boston Scientific, Bristol-Myers Squibb, Cordis Johnson & Johnson, CSL, Medtronic, MSD, Pfizer, Sanofi-Aventis, Servier, Schering-Plough, and The Medicines Company. These companies do not have access to data and do not have the right to review manuscripts or abstracts before publication. Professor Duffy's and Professor Reid's work is supported by National Health and Medical Research Council of Australia grants.